Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 9, 2020 - Sedor Pharmaceuticals announced the FDA approval of Sesquient (fosphenytoin sodium).
Download PDF
Return to publications
